Super-antigen fusion proteins and the use thereof

Details for Australian Patent Application No. 2005203173 (hide)

Owner Healthbanks Biotech Co., Ltd.

Inventors Chang, Hsiu-Kang; Cheng, Wen-Fang; Liao, Chao-We

Agent Spruson & Ferguson

Pub. Number AU-B-2005203173

Priority 093121720 21.07.04 TW

Filing date 21 July 2005

Wipo publication date 9 February 2006

Acceptance publication date 9 August 2007

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 39/215 (2006.01) Medicinal preparations containing antigens or antibodies - Coronaviridae, e.g. avian infectious bronchitis virus

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/165 (2006.01) Peptides having more than 20 amino acids

C12N 15/50 (2006.01) Mutation or genetic engineering

Event Publications

4 August 2005 Complete Application Filed

  Priority application(s): 093121720 21.07.04 TW

9 February 2006 Application Open to Public Inspection

  Published as AU-B-2005203173

9 August 2007 Application Accepted

  Published as AU-B-2005203173

6 December 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005203174-Welding wire positioning system

2005203172-Intersecting laser line generating device